Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics

Publikation: Bidrag til bog/antologi/rapport/proceedingBidrag til bog/antologiForskningpeer review

  • Yunpeng Cai
  • ,
  • Chenguang Lou, Syddansk Universitet
  • ,
  • Jesper Wengel, Syddansk Universitet
  • ,
  • Kenneth A. Howard

Prolonged circulation and modulation of the pharmacokinetic profile are important to improve the clinical potential of antisense oligonucleotides (ASOs). Gapmer ASOs demonstrate excellent nuclease stability and robust gene silencing activity without the requirement of transfection agents. A major challenge for in vivo applications, however, is the short blood circulatory half-life. This work describes utilization of the long circulation of serum albumin to increase the blood residence time of gapmer ASOs. The method introduces fatty acid modifications into the gapmer ASOs design to exploit the binding and transport property of serum albumin for endogenous ligands. The level of albumin-gapmer ASOs interaction, blood circulatory half-life and biodistribution was dependent on number, position, and fatty acid type (palmitic or myristic acid) within the gapmer ASO sequence and either phosphorothioate or phosphodiester backbone modifications. This work offers a strategy to optimize gapmer ASO pharmacokinetics by a proposed endogenous assembly process with serum albumin that can be tuned by gapmer ASO design modifications.

Titel Gapmers : Methods and Protocols
RedaktørerToshifumi Yokota, Rika Maruyama
Antal sider12
ForlagHumana Press
ISBN (trykt)978-1-0716-0770-1
ISBN (Elektronisk)978-1-0716-0771-8
StatusUdgivet - 2020
SerietitelMethods in Molecular Biology

Se relationer på Aarhus Universitet Citationsformater

ID: 196365810